[{"uuid": "640a71e2-5741-4a92-a120-62aeb9183a1a", "publishTime": "2021-10-11T18:07:13.000Z", "title": "Judicial panel consolidates Philips CPAP, J&J sunscreen litigation", "description": "A federal judicial panel on Friday granted motions to consolidate pretrial proceedings for more than 110 federal lawsuits against CPAP-maker Philips, and for at least 16 actions over Johnson & Johnson\u2019s Neutrogena- and Aveeno-brand aerosol sunscreens.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/legal/litigation/judicial-panel-consolidates-philips-cpap-jj-sunscreen-litigation-2021-10-11/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/DElQnXAudktze9dI3zivCSgNvuQ=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/KBLWWHJWXZIQLC242C5MDJNEME.jpg"], "lang": "en", "cityfalconScore": 61, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 4, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "b1c071ae-d450-4e9f-925e-da37c671c730", "publishTime": "2021-10-15T17:47:25.000Z", "title": "FDA panel recommend Johnson & Johnson COVID boosters for people 18 and older", "description": "The Johnson & Johnson COVID vaccine boosters would be available for people 18 and older.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://fortune.com/2021/10/15/fda-advisors-unanimously-back-johnson-and-johnson-covid-boosters-for-people-18-and-older/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&xid=soc_socialflow_twitter_FORTUNE", "imageUrls": ["https://content.fortune.com/wp-content/uploads/2021/10/GettyImages-1234349941.jpg?resize=1200,600"], "lang": "en", "cityfalconScore": 60, "additionalData": {}, "source": {"name": "fortune.com", "brandName": "Fortune", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "5239a0c6-883e-4478-ac97-044cdeb141eb", "publishTime": "2021-09-17T22:33:01.000Z", "title": "Johnson & Johnson gears up for showdown over reorg votes with ex-talc supplier", "description": "Johnson & Johnson will urge a judge on Monday to disqualify certain votes in favor of a reorganization plan proposed by its former talc supplier, saying the votes were improperly changed in an attempt to secure necessary creditor support for the deal.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/legal/transactional/johnson-johnson-gears-up-showdown-over-reorg-votes-with-ex-talc-supplier-2021-09-17/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/HveA35deA56BPCBF9xAyjZSKLN8=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/JNWZODNLCRJQBL7264WN3IIJ6E.jpg"], "lang": "en", "cityfalconScore": 59, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ff47066d-7ba2-4f45-a5a8-385248a2007c", "publishTime": "2021-10-13T23:11:53.000Z", "title": "Ex-J&J talc supplier considering new path as judge nixes bankruptcy plan votes", "description": "The judge overseeing Imerys Talc America Inc\u2019s bankruptcy on Wednesday eliminated more than 15,000 personal injury claimants\u2019 votes on the former Johnson & Johnson talc supplier\u2019s proposed Chapter 11 plan, forcing the company to revisit its restructuring strategy.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/legal/transactional/ex-jj-talc-supplier-considering-new-path-judge-nixes-bankruptcy-plan-votes-2021-10-13/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/HveA35deA56BPCBF9xAyjZSKLN8=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/JNWZODNLCRJQBL7264WN3IIJ6E.jpg"], "lang": "en", "cityfalconScore": 57, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "7bf9d556-f236-4048-a631-45426ba119af", "publishTime": "2021-10-14T23:28:38.000Z", "title": "J&J puts talc liabilities into bankruptcy", "description": "Johnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer, offloading the potential liabilities into a newly created subsidiary hived off from the rest of the healthcare conglomerate.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-unit-manage-talc-claims-files-bankruptcy-protection-2021-10-14/?taid=6168bd8c35a2610001ad42f7&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/EBfUCZr2JYQTMQ4Ro0L7O3KkYfc=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ER6DY42JFBKE5BJLHFF7NVQTG4.jpg"], "lang": "en", "cityfalconScore": 57, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "3336dd9b-113d-44de-bb3e-68887a86173a", "publishTime": "2021-09-20T23:23:02.000Z", "title": "Judge mulls Johnson & Johnson bid to block vote changes in ex-talc supplier bankruptcy", "description": "Johnson & Johnson on Monday attempted to discredit efforts by lawyers representing personal injury claimants to change their votes on the restructuring plan of J&J's former talc supplier, Imerys Talc America Inc.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/legal/transactional/judge-mulls-johnson-johnson-bid-block-vote-changes-ex-talc-supplier-bankruptcy-2021-09-20/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/uyHXHkiruqMl6Ay-vGOhXu0-MpQ=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/3IDPIBLBBRON7ECX6O4ZRI4F4Y.jpg"], "lang": "en", "cityfalconScore": 56, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "c86a15f2-4845-418f-aacd-dd89da3651a3", "publishTime": "2021-10-15T17:42:30.000Z", "title": "U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine", "description": "A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/world/us/us-fda-advisers-vote-favor-booster-jj-covid-19-vaccine-2021-10-15/?taid=6169cc3335a2610001ad7e91&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/KBKuCjRMKaKh4RYD7W__nOJHU7A=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/3O6TWLM4MRORJLOKPQZ4IKLSUU.jpg"], "lang": "en", "cityfalconScore": 55, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 3, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "c225b363-3292-4d13-808a-db786561fdf5", "publishTime": "2021-09-30T01:28:56.000Z", "title": "MDL Watch: Panel to weigh CPAP, sunscreen actions", "description": "The Judicial Panel on Multidistrict Litigation on Thursday will hear motions to consolidate or coordinate pretrial proceedings for more than 90 lawsuits against CPAP-maker Philips Respironics, and for at least 16 actions over Johnson & Johnson Consumer Inc\u2019s Neutrogena and Aveeno brand aerosol sunscreens.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/legal/litigation/mdl-watch-panel-weigh-cpap-sunscreen-actions-2021-09-29/?taid=6155513fc9cd47000133673c&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/DElQnXAudktze9dI3zivCSgNvuQ=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/KBLWWHJWXZIQLC242C5MDJNEME.jpg"], "lang": "en", "cityfalconScore": 55, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "8d165747-abcd-4ab4-9da3-a8b2adfa5eb4", "publishTime": "2021-10-15T21:26:56.000Z", "title": "Second J&J COVID shot gets expert backing; FDA looking at lowering age for Pfizer booster", "description": "Outside advisers to the U.S. Food and Drug Administration on Friday unanimously recommended the agency authorize a second shot of Johnson & Johnson's COVID-19 vaccine for all recipients of the one-dose inoculation.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/world/us/us-fda-advisers-vote-jj-covid-19-vaccine-booster-2021-10-15/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/GPJEGLsN89398umvQy8Xe2ZFFCw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/EGJVBEQTQZPJTJWV6IMJ67F23Q.jpg"], "lang": "en", "cityfalconScore": 55, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "dfd3232d-0d85-420e-9470-009c2a4dca43", "publishTime": "2021-10-12T14:21:44.000Z", "title": "FDA panel will advise on Johnson & Johnson booster shots this week", "description": "Moderna and Johnson & Johnson COVID booster shots may soon be available to Americans.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://fortune.com/2021/10/12/fda-panel-will-advise-on-johnson-and-johnson-booster-shots-this-week/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&xid=soc_socialflow_twitter_FORTUNE", "imageUrls": ["https://content.fortune.com/wp-content/uploads/2021/10/AP21284722553815.jpg?resize=1200,600"], "lang": "en", "cityfalconScore": 55, "additionalData": {}, "source": {"name": "fortune.com", "brandName": "Fortune", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "57c257c5-2e8e-4979-9e2a-010ce9f381ba", "publishTime": "2021-10-13T21:18:57.000Z", "title": "J&J shot performs best paired with booster dose from Moderna or Pfizer, NIH study suggests", "description": "People who got Johnson & Johnson Inc\u2019s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc /BioNTech SE or Moderna Inc , a study run by the National Institutes of Health showed on Wednesday.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-covid-19-booster-shots-safe-says-nih-study-2021-10-13/?taid=61674d820fbc4500016a2155&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/_QoOn6Ibs0g9mvH912zBzsSksWg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/3DNR3P5EIBPBTJ6LJGVUWXDINM.jpg"], "lang": "en", "cityfalconScore": 54, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 3, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "19b79e70-af60-48b6-8f90-82662cbbf6fa", "publishTime": "2021-10-05T13:54:26.000Z", "title": "Johnson & Johnson seeks FDA authorization for vaccine booster shots", "description": "Johnson & Johnson wants to provide booster shots for vaccinated Americans.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://fortune.com/2021/10/05/johnson-and-johnson-seeks-fda-authorization-for-vaccine-booster-shots/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&xid=soc_socialflow_twitter_FORTUNE", "imageUrls": ["https://content.fortune.com/wp-content/uploads/2021/10/AP21277754863372.jpg?resize=1200,600"], "lang": "en", "cityfalconScore": 53, "additionalData": {}, "source": {"name": "fortune.com", "brandName": "Fortune", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/435/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "67a2cf75-3cbb-4316-a7a4-bf631130f6cb", "publishTime": "2021-10-12T10:45:00.000Z", "title": "Johnson & Johnson\u2019s Top Scientist to Depart", "description": "Paul Stoffels is the second top J&J executive in recent weeks to announce plans to leave.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/johnson-johnsons-top-scientist-to-depart-11634035500?mod=e2tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.wsj.net/im-415254/social"], "lang": "en", "cityfalconScore": 50, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 0, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "06a0a81e-bcae-47b8-942e-ac6830e8109b", "publishTime": "2021-10-15T13:11:07.000Z", "title": "U.S. FDA advisers to vote on J&J vaccine booster", "description": "A panel of expert advisers to the U.S. health regulator is meeting on Friday to vote on the authorization of a booster shot of Johnson & Johnson's vaccine for people aged 18 and older, and the appropriate interval between the two doses.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.reuters.com/world/us/us-fda-advisers-vote-jj-vaccine-booster-2021-10-15/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://www.reuters.com/resizer/fFMjoth7z_3ncsn2ZEKlkvfk28s=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WR7ZKPQBQFNDRBD4UNCUYFSNN4.jpg"], "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "reuters.com", "brandName": "Reuters", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1652606/large.png"}}, "duplicatesCount": 4, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "9770c513-200b-4eba-a5f4-2ea6295e8f60", "publishTime": "2021-10-14T10:16:36.000Z", "title": "Coronavirus tally: Global cases of COVID-19 top 239 million as FDA panel meets on Moderna booster", "description": "The global tally for the coronavirus-borne illness climbed above 239 million on Thursday, while the death toll edged above 4.87 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 44.7 million cases and 719,530 deaths. The U.S. is averaging close to 1,900 deaths a day, according to a New York Times tracker, , although new cases and hospitalizations are declining. a Food and Drug Administration advisory committee will meet later Thursday to discuss and take a vote on whether to authorize a booster dose for people vaccinated with the Moderna vaccine. The committee will reconvene on Friday to discuss boosters for the Johnson & Johnson shot. India is second by cases after the U.S. at 34 million and has suffered 451,435 deaths. Brazil has second highest death toll at 601,574 and 21.6 million cases. In Europe, Russia has most fatalities at 215,438, followed by the U.K. at 138,487. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/Xg0o0e-pRVU/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "731e28a7-5cd4-4d19-b678-2e5759486ae3", "publishTime": "2021-09-21T10:57:12.000Z", "title": "Coronavirus tally: Global cases of COVID-19 top 229 million and J&J says booster vaccine shot increases antibodies", "description": "The global tally for the coronavirus-borne illness climbed above 229 million on Tuesday, while the death toll rose to 4.70 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 42.3 million cases and 676,261 deaths. The U.S. is now averaging 2,087 deaths a day, according to a New York Times tracker, the most since March 1, and are almost entirely unvaccinated people. West Virginia, an early vaccine success story, has now become the state with the most new cases measured on a per capita basis and is counting about 2,000 new cases a day, the most since the start of the outbreak. Johnson & Johnson said data from a Phase 3 trial and real-world evidence confirm that its single-shot COVID-19 vaccine offers strong and long-lasting protection against hospitalization and death. The company said further data shows that a booster shot offers increased protection and antibodies. India is second by cases after the U.S. at 33.5 million and has suffered 445,385 deaths.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/_vkGmVGPMgM/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "e1ae98d1-9ba4-4b23-affc-19bac28eb8f9", "publishTime": "2021-09-24T18:27:29.000Z", "title": "Johnson & Johnson stock rises Tuesday, outperforms market", "description": "Johnson & Johnson stock rises Tuesday, outperforms market MarketWatch", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/story/johnson-johnson-stock-rises-tuesday-outperforms-market-01632256373-424b0a88c54d?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "82cee358-1978-42ee-9626-8a1afe40e41e", "publishTime": "2021-10-04T10:32:06.000Z", "title": "Coronavirus tally: Global cases of COVID-19 near 235 million and J&J to seek FDA authorization for booster", "description": "The global tally for the coronavirus-borne illness climbed above 234.9 million on Monday, while the death toll rose above 4.8 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 43.7 million cases and 701,176 deaths, after passing 700,000 late Friday. The U.S. is now averaging almost 2,000 deaths a day, according to a New York Times tracker, , a slight improvement over recent trends and new cases and hospitalizations are declining. Johnson & Johnson and Moderna have applied for authorization from the FDA for their COVID-19 vaccine boosters and an advisory committee will discuss them at a meeting scheduled for Oct. 14 and Oct. 15. Separately, the CEO of BioNTEch told the FT that COVID-19 is likely to continue mutating to the point where it can escape vaccines and immune systems and that a new vaccine may be required in the future. India is second by cases after the U.S. at 33.8 million and has suffered 448,997 deaths. Brazil has second highest death toll at 597,948 and 21.5 million cases.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/nTDTmVaX9pQ/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ad7d12ed-7a4b-4e11-984f-fa6767142dcb", "publishTime": "2021-10-04T17:04:36.000Z", "title": "J&J to test experimental RSV vaccine in 23,000 people in Phase 3 clinical study", "description": "Johnson & Johnson experimental respiratory syncytial virus (RSV) vaccine had an 80% efficacy rate against the virus, which can lead to bronchitis and pneumonia, according to new clinical data shared Saturday. It had a slightly lower efficacy rate of 70% when it comes to preventing symptomatic respiratory infections caused by the virus. The Phase 2b clinical trial is evaluating the vaccine candidate in 5,782 people 65 years old and older in the U.S. J&J said it launched the Phase 3 study and now plans to test the investigational RSV vaccine in 23,000 people who are 60 years old and older. J&J's stock has gained 1.2% so far this year, while the broader S&P 500 is up 14.7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/qNcTghVyRQM/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "21f7f03b-8d07-4f9e-ad88-bfac14ba4891", "publishTime": "2021-10-05T11:40:09.000Z", "title": "Johnson & Johnson Submits Data to FDA Supporting Covid-19 Booster Shot - Morningstar", "description": "Johnson & Johnson Submits Data to FDA Supporting Covid-19 Booster Shot Morningstar.com", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.morningstar.com/news/dow-jones/202110054377/johnson-johnson-submits-data-to-fda-supporting-covid-19-booster-shot?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "morningstar.com", "brandName": "Morningstar", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/8881/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/8881/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/8881/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/8881/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/8881/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "5a1e3534-6d64-450e-944b-ccc344f8316b", "publishTime": "2021-10-12T10:45:00.000Z", "title": "Johnson & Johnson's Top Scientist to Depart", "description": "Paul Stoffels is the second top J&J executive in recent weeks to announce plans to leave.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/johnson-johnsons-top-scientist-to-depart-11634035500?mod=pls_whats_news_us_business_f&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 0, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "11c14827-d5eb-4806-a085-5cd7dcd0249b", "publishTime": "2021-10-12T14:16:03.000Z", "title": "J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiring", "description": "Dr. Paul Stoffels, the executive running Johnson & Johnson's COVID-19 vaccine program, announced he will retire at the end of the year, the company said Tuesday. As J&J's chief scientific officer and vice chair of the executive committee, Stoffels is in charge of the company's research and product pipeline. He previously ran J&J's pharmaceuticals business. J&J CEO Alex Gorsky announced in August that he is stepping down at the end of 2021. J&J's stock is down 1.0% for the year, while the broader S&P 500 has gained 16.1%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/bHW6RUzNe4o/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ce46b0c5-818d-4bba-897b-ffda8a39cafa", "publishTime": "2021-10-13T15:32:13.000Z", "title": "White House says an estimated 7 million people have received a COVID-19 booster", "description": "The number of people in the U.S who are eligible to get a COVID-19 but have not been vaccinated has decreased to 66 million individuals, compared with 97 million people who met these criteria back in late July, according to White House officials. \"There's stronger evidence that vaccination requirements are working,\" Jeff Zients, the White House's COVID-19 response coordinator, said Wednesday during a press briefing. \"They're driving up vaccination rates.\" He also said that an estimated 7 million people in the U.S. have gotten a COVID-19 booster shot; 3 million of those shots were administered in the last week. The only COVID-19 shot that is currently authorized is the one developed by BioNTech SE and Pfizer Inc. . A Food and Drug Administration advisory committee is scheduled to meet Thursday and Friday to discuss whether the regulator should authorize Moderna Inc.'s and Johnson & Johnson's booster shots. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/fpvb625Uu0M/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "e5e843e4-d360-40e5-9bf4-348b4a84b013", "publishTime": "2021-10-13T15:10:00.000Z", "title": "J&J Booster Dose Bolsters Protection Against Covid-19, FDA Says", "description": "Federal health regulators cautioned that data was limited and that they had to rely on Johnson & Johnson\u2019s own analysis for some of the study findings, rather than conducting their own.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/johnson-johnson-covid-19-booster-shot-bolsters-immune-defense-fda-staff-say-11634137515?mod=pls_whats_news_us_business_f&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 0, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "cc488bf9-affd-4bba-b694-bc0b873b0b86", "publishTime": "2021-10-13T20:24:34.000Z", "title": "'Mixing' COVID-19 vaccines triggers a stronger immune response, preliminary NIH study says", "description": "Giving people a different COVID-19 booster than the vaccine series that they originally received is safe and generates an immune response that is stronger, according to a preprint study conducted by the National Institutes of Health. (At this time, only BioNTech and Pfizer Inc.'s COVID-19 booster has been authorized for people who were previously vaccinated with that vaccine series.) The preprint, which was published Wednesday in advance of a public presentation set for Friday afternoon, evaluates all three authorized or approved COVID-19 vaccines in the U.S. in 458 participants as part of a \"mix-and-match\" clinical trial. With the exception of the people who were exclusively vaccinated and boosted with Johnson & Johnson's shots, all participants reported efficacy rates of at least 90.7%. \"These data strongly suggest that homologous and heterologous booster vaccine will increase protective efficacy against symptomatic SARS-CoV-2 infection,\" the authors wrote. There are, however, some limitations to the research.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/vThtmRB_ptk/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "bc876728-a311-418e-ae82-15ab0f75ce92", "publishTime": "2021-10-15T10:16:37.000Z", "title": "Coronavirus tally: Global cases of COVID-19 head toward 240 million and FDA panel endorses Moderna boosters for some", "description": "The global tally for the coronavirus-borne illness climbed above 239.6 million on Friday, while the death toll edged above 4.88 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 44.8 million cases and 721,567 deaths. The U.S. is averaging more than 1,800 deaths a day, according to a New York Times tracker, , although new cases and hospitalizations are declining. A Food and Drug Administration advisory committee said Thursday that some Americans who received Moderna COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus. The panel of outside advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, as well as younger adults with other health problems, jobs or living situations that put them at increased risk from COVID-19.The committee will reconvene on Friday to discuss boosters for the Johnson & Johnson shot. ", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/UFlHteZ4qX8/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "6241c63e-936f-41b9-9aa5-c58164603c1f", "publishTime": "2021-10-05T14:08:00.000Z", "title": "Johnson & Johnson Asks FDA to Authorize Covid-19 Booster", "description": "The extra dose increased protection to 94% against moderate to severe Covid-19 in a late-stage trial in the U.S., the company said.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/johnson-johnson-asks-fda-to-authorize-covid-19-booster-11633442928?mod=e2tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.wsj.net/im-411609/social"], "lang": "en", "cityfalconScore": 45, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 1, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "8534306c-73b8-4268-b781-d49257678ba1", "publishTime": "2021-09-21T10:30:00.000Z", "title": "J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection", "description": "Johnson & Johnson said a booster dose of its Covid-19 vaccine administered two months after the first shot increased protection against symptomatic illness in trial participants.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/j-j-says-covid-19-vaccine-booster-two-months-after-first-shot-increases-protection-11632220201?mod=e2tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.wsj.net/im-404067/social"], "lang": "en", "cityfalconScore": 43, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 3, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "d2d000f8-eefa-4007-b9de-664e92b955f7", "publishTime": "2021-10-15T17:39:00.000Z", "title": "FDA committee says it's safe for all adults who got J&J's COVID-19 vaccine to get a booster", "description": "The Food and Drug Administration should authorize a second 'booster' dose of Johnson & Johnson's COVID-19 vaccine for adults who were initially immunized...", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/story/fda-committee-says-its-safe-for-all-adults-who-got-j-js-covid-19-vaccine-to-get-a-booster-11634319561?siteid=bullytweet&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.mktw.net/im-391005/social"], "lang": "en", "cityfalconScore": 43, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "006eb6ee-ba4c-4ef9-b0c5-3db267b119ee", "publishTime": "2021-10-05T12:27:00.000Z", "title": "Johnson & Johnson Sends Booster Data To FDA. Here\u2019s What Comes Next.", "description": "The announcement comes two weeks after the company presented the results of a randomized, controlled Phase 3 study showing that a booster dose offered 75%...", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/articles/johnson-johnson-covid-vaccine-booster-jnj-51633436726?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.barrons.com/im-411538/social"], "lang": "en", "cityfalconScore": 41, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "c56e3d10-3b2f-482e-ad2a-bedb85627602", "publishTime": "2021-09-21T00:00:00.000Z", "title": "J&J Booster Shot Offers 94% Protection Against Symptomatic Covid, Company Says", "description": "A second dose of Johnson & Johnson\u2019s Covid-19 vaccine given two months after the first offered study participants 100% protection against severe or critical illness from the coronavirus.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.forbes.com/sites/roberthart/2021/09/21/jj-booster-shot-offers-94-protection-against-symptomatic-covid-company-says/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Gordie", "imageUrls": ["https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F6149bd2fb94ffc3c46b031cd%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D4426%26cropY1%3D220%26cropY2%3D2711"], "lang": "en", "cityfalconScore": 38, "additionalData": {}, "source": {"name": "forbes.com", "brandName": "Forbes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ebbff48d-a0ba-492f-ba74-d16bf5baf9cb", "publishTime": "2021-09-21T12:54:19.000Z", "title": "Second Booster Dose Of Johnson & Johnson COVID Vaccine Shows Increased Protection Against Virus", "description": "Johnson & Johnson said the booster shot has a 94% effectiveness against COVID-19 when administered two months after the first dose.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.ibtimes.com/second-booster-dose-johnson-johnson-covid-vaccine-shows-increased-protection-against-3300561?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Autofeed#Echobox=1632228987", "imageUrls": ["https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2021/04/23/us-experts-say-the-johnson-johnson-covid-vaccine.jpg"], "lang": "en", "cityfalconScore": 36, "additionalData": {}, "source": {"name": "ibtimes.com", "brandName": "IBTimes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "61eb480e-4a0d-4b47-ace8-13a3ec9ce83e", "publishTime": "2021-10-06T12:12:12.000Z", "title": "4th Person Dies In US From Rare Blood Clot After Receiving Johnson & Johnson COVID Vaccine", "description": "The woman, who was in her late 30s, is the fourth U.S. death reported from a rare blood clot condition after receiving the Johnson & Johnson shot.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.ibtimes.com/4th-person-dies-us-rare-blood-clot-after-receiving-johnson-johnson-covid-vaccine-3310738?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Autofeed#Echobox=1633522439", "imageUrls": ["https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2021/02/10/south-africa-says-it-will-use-the-johnson.jpg"], "lang": "en", "cityfalconScore": 36, "additionalData": {}, "source": {"name": "ibtimes.com", "brandName": "IBTimes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "77802075-b6ee-4cdb-ab3f-d18a1b94f123", "publishTime": "2021-10-13T00:00:00.000Z", "title": "FDA Says J&J Covid Booster Likely Boosts Immunity, But Evidence Isn\u2019t Full-Proof", "description": "An advisory panel will review the argument for second Johnson & Johnson doses Friday.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.forbes.com/sites/carlieporterfield/2021/10/13/fda-says-jj-covid-booster-likely-boosts-immunity-but-evidence-isnt-full-proof/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Gordie", "imageUrls": ["https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F6167203420c257730f3c20ed%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D2857%26cropY1%3D51%26cropY2%3D1658"], "lang": "en", "cityfalconScore": 36, "additionalData": {}, "source": {"name": "forbes.com", "brandName": "Forbes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ec79becc-3b61-4bef-b140-635f0bb8accb", "publishTime": "2021-09-17T18:44:00.000Z", "title": "Moderna\u2019s Covid-19 Vaccine Best Prevents Hospitalization, CDC Study Indicates", "description": "Research showed Johnson & Johnson shot offered the least protection against hospitalization over time.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/modernas-covid-19-vaccine-best-prevents-hospitalization-cdc-study-says-11631904252?mod=e2tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.wsj.net/im-402868/social"], "lang": "en", "cityfalconScore": 35, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 3, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "1b8bd147-f1fa-4799-b29d-bec5b390cf37", "publishTime": "2021-10-05T00:00:00.000Z", "title": "Johnson & Johnson Submits Booster Shot Data To FDA For Approval", "description": "The company has released data suggesting the second shot offers strong protection against Covid-19.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.forbes.com/sites/alisondurkee/2021/10/05/johnson--johnson-submits-booster-shot-data-to-fda-for-approval/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Gordie", "imageUrls": ["https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61226872f6329b8eb508ccdd%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D3529%26cropY1%3D16%26cropY2%3D2002"], "lang": "en", "cityfalconScore": 35, "additionalData": {}, "source": {"name": "forbes.com", "brandName": "Forbes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "b32b6175-2da9-4ab7-b679-f7846e6e644e", "publishTime": "2021-10-14T13:46:13.000Z", "title": "FDA advisors prepare to vote on Moderna, J&J Covid boosters", "description": "A group of expert FDA advisors plan to meet over the coming days to discuss Moderna's and Johnson & Johnson's applications for a Covid-19 booster. CNBC's Meg Tirrell reports.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.cnbc.com/video/2021/10/14/fda-expert-advisors-prepare-to-vote-on-moderna-jj-covid-boosters.html?__source=sharebar%7Ctwitter&par=sharebar&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://image.cnbcfm.com/api/v1/image/106960373-16342167401634216738-19211238126-1080pnbcnews.jpg?v=1634216739"], "lang": "en", "cityfalconScore": 35, "additionalData": {}, "source": {"name": "cnbc.com", "brandName": "CNBC", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "93acc391-fca2-4056-9849-e87721e5d68c", "publishTime": "2021-09-21T14:55:00.000Z", "title": "J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision", "description": "Johnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real...", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/story/j-j-says-booster-greatly-improves-covid-19-vaccine-efficacy-as-experts-await-fda-decision-11632236156?siteid=bullytweet&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.mktw.net/im-404373/social"], "lang": "en", "cityfalconScore": 34, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "51b6433d-da42-424b-9b36-dc70b3adf2f6", "publishTime": "2021-09-21T00:00:00.000Z", "title": "J&J Booster Shot Offers Strong Protection Against Symptomatic Covid, Company Says", "description": "A second dose of Johnson & Johnson\u2019s Covid-19 vaccine given two months after the first offered study participants 100% protection against severe or critical illness from the coronavirus.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.forbes.com/sites/roberthart/2021/09/21/jj-booster-shot-offers-94-protection-against-symptomatic-covid-company-says/?sh=4b860f3f1d6e&utm_campaign=cityfalcon&utm_content=5539071443&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F6149bd2fb94ffc3c46b031cd%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D4426%26cropY1%3D220%26cropY2%3D2711"], "lang": "en", "cityfalconScore": 34, "additionalData": {}, "source": {"name": "forbes.com", "brandName": "Forbes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "1168ee90-1e09-447c-921e-e1416094b9f4", "publishTime": "2021-09-30T01:38:35.000Z", "title": "Woman Dies Of Brain Hemorrhage Just Days After Receiving J&J COVID-19 Vaccine", "description": "The Slovenian government has now temporarily suspended the use of the Johnson&Johnson COVID-19 vaccine.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.ibtimes.com/woman-dies-brain-hemorrhage-just-days-after-receiving-jj-covid-19-vaccine-3307179?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon&utm_term=Autofeed#Echobox=1632966004", "imageUrls": ["https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2021/04/20/europes-drug-regulator-was-set-tuesday-to-rule.jpg"], "lang": "en", "cityfalconScore": 33, "additionalData": {}, "source": {"name": "ibtimes.com", "brandName": "IBTimes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/676/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "ff1b4f31-d957-41ee-b11b-53309383cabb", "publishTime": "2021-10-15T15:02:00.000Z", "title": "FDA advisory committee to vote on Johnson & Johnson COVID-19 booster, a day after endorsing the Moderna one", "description": "One day after a U.S. Food and Drug Administration advisory panel voted to endorse a booster shot of the Moderna vaccine for seniors and other at-risk groups,...", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/story/fda-advisory-committee-to-vote-on-johnson-johnson-covid-19-booster-a-day-after-endorsing-the-moderna-one-11634310168?link=sfmw_tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.mktw.net/im-417936/social"], "lang": "en", "cityfalconScore": 33, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "9979d034-6121-42f8-8318-cf33205c7894", "publishTime": "2021-10-05T10:42:09.000Z", "title": "J&J amends FDA EUA submission for COVID-19 booster with data showing 94% protection against moderate to severe illness", "description": "Johnson & Johnson undefined said Tuesday it has submitted an amendment to the emergency use authorization it's seeking from the U.S. Food and Drug...", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.marketwatch.com/story/jj-amends-fda-eua-submission-for-covid-19-booster-with-data-showing-94-protection-against-moderate-to-severe-illness-2021-10-05?siteid=bullytweet&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg"], "lang": "en", "cityfalconScore": 32, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 2, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "1ca97cd3-a28f-4550-8e29-a53f31562630", "publishTime": "2021-10-15T17:29:53.000Z", "title": "FDA panel unanimously recommends J&J Covid booster shots to adults who already got the first dose", "description": "An influential Food and Drug Administration advisory committee on Friday said the agency should authorize boosters of Johnson & Johnson's single-shot Covid-19 vaccine to the more than 15 million Americans who have already received the initial dose.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.cnbc.com/2021/10/15/fda-panel-unanimously-recommends-jj-covid-booster-shots-to-millions-of-americans.html?__source=iosappshare%7Ccom.apple.UIKit.activity.PostToTwitter&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://image.cnbcfm.com/api/v1/image/106873772-1619447661679-gettyimages-1232533653-04252021_PHH_Vaccine_05.jpeg?v=1634302567"], "lang": "en", "cityfalconScore": 32, "additionalData": {}, "source": {"name": "cnbc.com", "brandName": "CNBC", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1665829/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}, {"uuid": "6e4ff615-6de3-4241-acc7-a101c8ce9f57", "publishTime": "2021-10-13T15:10:00.000Z", "title": "Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say", "description": "Federal health regulators cautioned that data was limited and they had to rely on Johnson & Johnson\u2019s own analysis for some of the study findings, rather than conducting their own.", "assetTags": ["Johnson & Johnson", "JNJ NYSE", "JNJ US"], "searchTags": ["JNJ"], "category": "major_publication", "url": "https://www.wsj.com/articles/johnson-johnson-covid-19-booster-shot-bolsters-immune-defense-fda-staff-say-11634137515?mod=e2tw&utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://images.wsj.net/im-416379/social"], "lang": "en", "cityfalconScore": 31, "additionalData": {}, "source": {"name": "wsj.com", "brandName": "The Wall Street Journal", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/1661160/large.png"}}, "duplicatesCount": 4, "paywall": true, "registrationRequired": true, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/johnson-johnson-jnj"}]